SCHEMBL22440366

SCHEMBL22440366

CN(C)C(=O)CN1CCC(C(=O)O)C1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
S1PR5 Q9H228 7/20 0.43
S1PR4 O95977 1/20 0.43
S1PR1 P21453 1/20 0.43
S1PR3 Q99500 1/20 0.43
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 1/20 0.38
CYP1A2 P05177 1/20 0.38
NOTUM Q6P988 1/20 0.38
BCHE P06276 1/20 0.37
PKM P14618 1/20 0.37
SIGMAR1 Q99720 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24131518 1.00 MEN1 (0.44) MEN1KMT2AS1PR5S1PR4S1PR1
SCHEMBL7517115 0.83 S1PR5 (0.41) S1PR5S1PR4S1PR1S1PR3SMN1; SMN2
SCHEMBL7398354 0.82 S1PR5 (0.44) MEN1KMT2AS1PR5S1PR4S1PR1
SCHEMBL19617145 0.81 MEN1 (0.47) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL1007316 0.78 SMN1; SMN2 (0.44) S1PR5S1PR4S1PR1S1PR3ALDH1A1
SCHEMBL8290943 0.78 MEN1 (0.49) MEN1KMT2AALDH1A1SIGMAR1
SCHEMBL7459216 0.78 SMN1; SMN2 (0.44) S1PR5S1PR4S1PR1S1PR3ALDH1A1
SCHEMBL1008401 0.78 SMN1; SMN2 (0.44) S1PR5S1PR4S1PR1S1PR3ALDH1A1
SCHEMBL7402269 0.78 SIGMAR1 (0.54) MEN1KMT2AS1PR5S1PR4S1PR1
SCHEMBL13739335 0.77 SMN1; SMN2 (0.57) S1PR5S1PR4S1PR1S1PR3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021254254-A1 ORGANIC ARSENIC-BASED TYPE II PYRUVATE KINASE INHIBITOR AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF 中国科学院上海有机化学研究所 2021-12-23 WO disclosed
EP-3710439-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2020-09-23 EP disclosed